- Home
- HOWL vs GEG Comparison
HOWL vs GEG Comparison
Compare HOWL & GEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- GEG
- Stock Information
- Founded
- HOWL 2017
- GEG 1994
- Country
- HOWL United States
- GEG United States
- Employees
- HOWL N/A
- GEG N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- GEG Computer Software: Prepackaged Software
- Sector
- HOWL Health Care
- GEG Technology
- Exchange
- HOWL Nasdaq
- GEG Nasdaq
- Market Cap
- HOWL 64.5M
- GEG 72.4M
- IPO Year
- HOWL 2021
- GEG N/A
- Fundamental
- Price
- HOWL $1.22
- GEG $2.45
- Analyst Decision
- HOWL Strong Buy
- GEG
- Analyst Count
- HOWL 5
- GEG 0
- Target Price
- HOWL $7.20
- GEG N/A
- AVG Volume (30 Days)
- HOWL 891.7K
- GEG 13.4K
- Earning Date
- HOWL 11-04-2025
- GEG 11-11-2025
- Dividend Yield
- HOWL N/A
- GEG N/A
- EPS Growth
- HOWL N/A
- GEG N/A
- EPS
- HOWL N/A
- GEG 0.38
- Revenue
- HOWL N/A
- GEG $16,315,999.00
- Revenue This Year
- HOWL N/A
- GEG N/A
- Revenue Next Year
- HOWL N/A
- GEG N/A
- P/E Ratio
- HOWL N/A
- GEG $6.42
- Revenue Growth
- HOWL N/A
- GEG N/A
- 52 Week Low
- HOWL $0.60
- GEG $1.70
- 52 Week High
- HOWL $2.52
- GEG $3.51
- Technical
- Relative Strength Index (RSI)
- HOWL 33.34
- GEG 45.50
- Support Level
- HOWL $1.16
- GEG $2.45
- Resistance Level
- HOWL $1.83
- GEG $2.64
- Average True Range (ATR)
- HOWL 0.14
- GEG 0.08
- MACD
- HOWL -0.06
- GEG 0.00
- Stochastic Oscillator
- HOWL 18.67
- GEG 20.75
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About GEG Great Elm Group Inc.
Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.